O	O	O	0	11	Suppression	Suppression	B-NP	NN	O	0	ROOT	O
O	O	O	12	14	by	by	B-PP	IN	O	1	NMOD	O
O	O	O	15	25	azelastine	azelastine	B-NP	NN	O	4	NMOD	O
O	O	O	26	39	hydrochloride	hydrochloride	I-NP	NN	O	2	PMOD	O
O	O	O	40	42	of	of	B-PP	IN	O	4	NMOD	O
T6	B-Entity	B-Entity	43	45	NF	NF	B-NP	NN	B-protein	9	NMOD	B-protein
T6	I-Entity	I-Entity	45	46	-	-	B-NP	HYPH	I-protein	9	NMOD	I-protein
T6	I-Entity	I-Entity	46	51	kappa	kappa	I-NP	NN	I-protein	9	NMOD	I-protein
T6	I-Entity	I-Entity	52	53	B	B	I-NP	NN	I-protein	10	NMOD	I-protein
O	O	O	54	64	activation	activation	I-NP	NN	O	5	PMOD	O
O	O	O	65	73	involved	involve	B-VP	VBN	O	10	NMOD	O
O	O	O	74	76	in	in	B-PP	IN	O	11	VMOD	O
O	O	O	77	87	generation	generation	B-NP	NN	O	12	PMOD	O
O	O	O	88	90	of	of	B-PP	IN	O	13	NMOD	O
O	O	O	91	100	cytokines	cytokine	B-NP	NNS	B-protein	18	NMOD	B-protein
O	O	O	101	104	and	and	O	CC	O	18	NMOD	O
O	O	O	105	111	nitric	nitric	B-NP	JJ	O	18	NMOD	O
O	O	O	112	117	oxide	oxide	I-NP	NN	O	14	PMOD	O
O	O	O	117	118	.	.	O	.	O	1	P	O

O	O	O	120	123	The	The	B-NP	DT	O	2	NMOD	O
O	O	O	124	133	influence	influence	I-NP	NN	O	32	SUB	O
O	O	O	134	136	of	of	B-PP	IN	O	2	NMOD	O
O	O	O	137	140	the	the	B-NP	DT	O	10	NMOD	O
O	O	O	141	145	anti	anti	I-NP	AFX	O	10	NMOD	O
O	O	O	145	146	-	-	I-NP	HYPH	O	10	NMOD	O
O	O	O	146	153	allergy	allergy	I-NP	NN	O	10	NMOD	O
O	O	O	154	159	agent	agent	I-NP	NN	O	10	NMOD	O
O	O	O	160	170	azelastine	azelastine	I-NP	NN	O	10	NMOD	O
O	O	O	171	184	hydrochloride	hydrochloride	I-NP	NN	O	3	PMOD	O
O	O	O	185	186	(	(	O	(	O	13	DEP	O
O	O	O	186	193	Azeptin	Azeptin	B-NP	NN	O	13	DEP	O
O	O	O	193	194	)	)	O	)	O	10	NMOD	O
O	O	O	195	197	on	on	B-PP	IN	O	2	NMOD	O
T7	B-Entity	B-Entity	198	200	NF	NF	B-NP	NN	B-protein	19	NMOD	B-protein
T7	I-Entity	I-Entity	200	201	-	-	I-NP	HYPH	I-protein	19	NMOD	I-protein
T7	I-Entity	I-Entity	201	206	kappa	kappa	I-NP	NN	I-protein	19	NMOD	I-protein
T7	I-Entity	I-Entity	207	208	B	B	I-NP	NN	I-protein	19	NMOD	I-protein
O	O	O	209	219	activation	activation	I-NP	NN	O	14	PMOD	O
O	O	O	220	230	associated	associate	B-VP	VBN	O	19	NMOD	O
O	O	O	231	235	with	with	B-PP	IN	O	20	VMOD	O
O	O	O	236	239	the	the	B-NP	DT	O	23	NMOD	O
O	O	O	240	250	generation	generation	I-NP	NN	O	21	PMOD	O
O	O	O	251	253	of	of	B-PP	IN	O	23	NMOD	O
O	O	O	254	263	cytokines	cytokine	B-NP	NNS	B-protein	28	NMOD	B-protein
O	O	O	264	267	and	and	O	CC	O	28	NMOD	O
O	O	O	268	274	nitric	nitric	B-NP	JJ	O	28	NMOD	O
O	O	O	275	280	oxide	oxide	I-NP	NN	O	24	PMOD	O
O	O	O	281	282	(	(	O	(	O	31	DEP	O
O	O	O	282	284	NO	NO	B-NP	NN	O	31	DEP	O
O	O	O	284	285	)	)	O	)	O	28	NMOD	O
O	O	O	286	289	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	290	302	investigated	investigate	I-VP	VBN	O	32	VC	O
O	O	O	303	305	in	in	B-PP	IN	O	33	VMOD	O
O	O	O	306	313	various	various	B-NP	JJ	O	36	NMOD	O
O	O	O	314	319	kinds	kind	I-NP	NNS	O	34	PMOD	O
O	O	O	320	322	of	of	B-PP	IN	O	36	NMOD	O
O	O	O	323	328	human	human	O	JJ	B-cell_type	41	NMOD	B-cell_type
O	O	O	329	332	and	and	O	CC	I-cell_type	41	NMOD	I-cell_type
O	O	O	333	338	mouse	mouse	B-NP	NN	I-cell_type	41	NMOD	I-cell_type
O	O	O	339	344	cells	cell	B-NP	NNS	I-cell_type	37	PMOD	I-cell_type
O	O	O	344	345	.	.	O	.	O	32	P	O

O	O	O	346	353	Azeptin	Azeptin	B-NP	NN	O	2	NMOD	O
O	O	O	354	358	dose	dose	I-NP	NN	O	5	SUB	O
O	O	O	358	359	-	-	B-NP	HYPH	O	5	P	O
O	O	O	359	370	dependently	dependently	B-ADVP	RB	O	5	VMOD	O
O	O	O	371	381	suppressed	suppress	B-VP	VBD	O	0	ROOT	O
O	O	O	382	386	both	both	O	CC	O	10	NMOD	O
T8	B-Entity	B-Entity	387	390	DNA	DNA	B-NP	NN	O	10	NMOD	O
O	O	O	391	394	and	and	O	CC	O	10	NMOD	O
O	O	O	395	402	protein	protein	B-NP	NN	O	10	NMOD	O
O	O	O	403	412	synthesis	synthesis	I-NP	NN	O	5	OBJ	O
O	O	O	413	415	in	in	B-PP	IN	O	10	NMOD	O
O	O	O	416	421	human	human	B-NP	JJ	B-cell_type	14	NMOD	B-cell_type
O	O	O	422	430	gingival	gingival	I-NP	JJ	I-cell_type	14	NMOD	I-cell_type
O	O	O	431	442	fibroblasts	fibroblast	I-NP	NNS	I-cell_type	11	PMOD	I-cell_type
O	O	O	443	444	(	(	O	(	O	17	DEP	O
O	O	O	444	446	HF	HF	B-NP	NNS	B-cell_type	17	DEP	B-cell_type
O	O	O	446	447	)	)	O	)	O	14	NMOD	O
O	O	O	448	451	and	and	O	CC	O	5	VMOD	O
O	O	O	452	456	also	also	B-ADVP	RB	O	5	VMOD	O
O	O	O	457	467	suppressed	suppress	B-VP	VBD	O	5	VMOD	O
O	O	O	468	481	blastogenesis	blastogenesis	B-NP	NN	O	20	OBJ	O
O	O	O	482	484	of	of	B-PP	IN	O	21	NMOD	O
O	O	O	485	490	human	human	B-NP	JJ	B-cell_type	26	NMOD	B-cell_type
O	O	O	491	501	peripheral	peripheral	I-NP	JJ	I-cell_type	26	NMOD	I-cell_type
O	O	O	502	507	blood	blood	I-NP	NN	I-cell_type	26	NMOD	I-cell_type
O	O	O	508	519	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	22	PMOD	I-cell_type
O	O	O	520	521	(	(	O	(	O	29	DEP	O
O	O	O	521	524	PBL	PBL	B-NP	NN	B-cell_type	29	DEP	B-cell_type
O	O	O	524	525	)	)	O	)	O	26	NMOD	O
O	O	O	525	526	.	.	O	.	O	5	P	O

O	O	O	527	537	Generation	Generation	B-NP	NN	O	38	NMOD	O
O	O	O	538	540	of	of	B-PP	IN	O	1	NMOD	O
T1	B-Protein	B-Protein	541	546	tumor	tumor	B-NP	NN	B-protein	7	NMOD	B-protein
T1	I-Protein	I-Protein	547	555	necrosis	necrosis	I-NP	NN	I-protein	7	NMOD	I-protein
T1	I-Protein	I-Protein	556	562	factor	factor	I-NP	NN	I-protein	7	NMOD	I-protein
T1	I-Protein	I-Protein	562	563	-	-	O	HYPH	I-protein	7	P	I-protein
T1	I-Protein	I-Protein	563	568	alpha	alpha	B-NP	SYM	I-protein	12	NMOD	I-protein
O	O	O	568	569	,	,	O	,	O	12	P	O
T2	B-Protein	B-Protein	570	581	interleukin	interleukin	B-NP	NN	B-protein	12	NMOD	B-protein
T2	I-Protein	I-Protein	582	583	1	1	I-NP	CD	I-protein	9	NMOD	I-protein
T2	I-Protein	I-Protein	583	584	-	-	O	HYPH	O	9	P	O
T2	I-Protein	I-Protein	584	588	beta	beta	B-NP	SYM	O	2	PMOD	O
O	O	O	588	589	,	,	O	,	O	23	P	O
T3	B-Protein	B-Protein	590	601	granulocyte	granulocyte	B-NP	NN	B-protein	20	NMOD	B-protein
T3	I-Protein	I-Protein	601	602	-	-	O	HYPH	I-protein	20	NMOD	I-protein
T3	I-Protein	I-Protein	602	612	macrophage	macrophage	B-NP	NN	I-protein	20	NMOD	I-protein
T3	I-Protein	I-Protein	613	619	colony	colony	I-NP	NN	I-protein	20	NMOD	I-protein
T3	I-Protein	I-Protein	619	620	-	-	O	HYPH	I-protein	20	NMOD	I-protein
T3	I-Protein	I-Protein	620	631	stimulating	stimulate	B-VP	VBG	I-protein	20	NMOD	I-protein
T3	I-Protein	I-Protein	632	638	factor	factor	B-NP	NN	I-protein	23	NMOD	I-protein
O	O	O	639	642	and	and	I-NP	CC	O	23	NMOD	O
T4	B-Protein	B-Protein	643	654	interleukin	interleukin	I-NP	NN	B-protein	23	NMOD	B-protein
T4	I-Protein	I-Protein	654	655	-	-	O	HYPH	I-protein	12	NMOD	I-protein
T4	I-Protein	I-Protein	655	656	6	6	B-NP	CD	I-protein	23	NMOD	I-protein
O	O	O	657	661	from	from	B-PP	IN	O	1	NMOD	O
O	O	O	662	664	10	10	B-NP	CD	O	25	PMOD	O
O	O	O	664	665	(	(	O	(	O	30	DEP	O
O	O	O	665	666	-	-	O	SYM	O	30	DEP	O
O	O	O	666	667	5	5	O	CD	O	28	PRD	O
O	O	O	667	668	)	)	O	)	O	31	AMOD	O
O	O	O	669	670	M	M	B-NP	NN	O	32	NMOD	O
O	O	O	671	678	Azeptin	Azeptin	I-NP	NN	O	25	PMOD	O
O	O	O	678	679	-	-	O	HYPH	O	1	P	O
O	O	O	679	686	treated	treat	B-VP	VBN	O	38	NMOD	O
O	O	O	687	690	PBL	PBL	B-NP	NN	B-cell_type	38	NMOD	B-cell_type
O	O	O	691	694	and	and	O	CC	O	38	NMOD	O
O	O	O	695	700	human	human	B-NP	JJ	B-cell_type	38	NMOD	B-cell_type
O	O	O	701	710	monocytes	monocyte	I-NP	NNS	I-cell_type	42	SUB	I-cell_type
O	O	O	711	712	(	(	O	(	O	41	DEP	O
O	O	O	712	714	HM	HM	B-NP	NN	B-protein	41	DEP	B-protein
O	O	O	714	715	)	)	O	)	O	38	NMOD	O
O	O	O	716	719	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	720	729	decreased	decrease	I-VP	VBN	O	42	VC	O
O	O	O	730	732	to	to	B-PP	TO	O	43	VMOD	O
O	O	O	733	746	approximately	approximately	B-NP	RB	O	52	NMOD	O
O	O	O	747	748	1	1	I-NP	CD	O	45	AMOD	O
O	O	O	748	749	/	/	I-NP	SYM	O	45	AMOD	O
O	O	O	749	750	3	3	I-NP	CD	O	45	AMOD	O
O	O	O	751	753	to	to	I-NP	TO	O	45	AMOD	O
O	O	O	754	755	2	2	I-NP	CD	O	45	AMOD	O
O	O	O	755	756	/	/	I-NP	SYM	O	45	AMOD	O
O	O	O	756	757	3	3	I-NP	CD	O	44	PMOD	O
O	O	O	758	760	of	of	B-PP	IN	O	52	NMOD	O
O	O	O	761	764	the	the	B-NP	DT	O	56	NMOD	O
O	O	O	765	772	control	control	I-NP	NN	O	56	NMOD	O
O	O	O	773	779	levels	level	I-NP	NNS	O	53	PMOD	O
O	O	O	779	780	.	.	O	.	O	42	P	O

O	O	O	781	783	In	In	B-PP	IN	O	12	VMOD	O
O	O	O	784	792	parallel	parallel	B-NP	NN	O	1	PMOD	O
O	O	O	793	797	with	with	B-PP	IN	O	2	NMOD	O
O	O	O	798	801	the	the	B-NP	DT	O	7	NMOD	O
O	O	O	802	811	decreased	decrease	I-NP	VBN	O	7	NMOD	O
O	O	O	812	820	cytokine	cytokine	I-NP	NN	B-protein	7	NMOD	B-protein
O	O	O	821	831	generation	generation	I-NP	NN	O	3	PMOD	O
O	O	O	831	832	,	,	O	,	O	12	P	O
O	O	O	833	837	each	each	B-NP	DT	O	11	NMOD	O
O	O	O	838	846	cytokine	cytokine	I-NP	NN	B-RNA	11	NMOD	B-RNA
O	O	O	847	851	mRNA	mRNA	I-NP	NN	I-RNA	12	SUB	I-RNA
O	O	O	852	855	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	856	860	less	less	I-VP	RBR	O	12	VMOD	O
O	O	O	861	870	expressed	express	I-VP	VBN	O	12	VC	O
O	O	O	871	873	in	in	B-PP	IN	O	14	VMOD	O
O	O	O	874	877	the	the	B-NP	DT	O	17	NMOD	O
O	O	O	878	886	presence	presence	I-NP	NN	O	15	PMOD	O
O	O	O	887	889	of	of	B-PP	IN	O	17	NMOD	O
O	O	O	890	892	10	10	B-NP	CD	O	24	AMOD	O
O	O	O	892	893	(	(	O	(	O	23	DEP	O
O	O	O	893	894	-	-	O	SYM	O	23	DEP	O
O	O	O	894	895	5	5	O	CD	O	21	PRD	O
O	O	O	895	896	)	)	O	)	O	19	NMOD	O
O	O	O	897	898	M	M	B-NP	NN	O	25	NMOD	O
O	O	O	899	906	Azeptin	Azeptin	I-NP	NN	O	18	PMOD	O
O	O	O	906	907	.	.	O	.	O	12	P	O

O	O	O	908	910	In	In	B-PP	IN	O	19	VMOD	O
O	O	O	911	919	addition	addition	B-NP	NN	O	1	PMOD	O
O	O	O	919	920	,	,	O	,	O	19	P	O
O	O	O	921	925	both	both	B-NP	DT	O	8	NMOD	O
O	O	O	926	935	inducible	inducible	I-NP	JJ	O	8	NMOD	O
T5	B-Protein	B-Protein	936	942	nitric	nitric	I-NP	JJ	B-protein	8	NMOD	B-protein
T5	I-Protein	I-Protein	943	948	oxide	oxide	I-NP	NN	I-protein	8	NMOD	I-protein
T5	I-Protein	I-Protein	949	957	synthase	synthase	I-NP	NN	I-protein	11	NMOD	I-protein
O	O	O	957	958	-	-	B-NP	HYPH	O	11	NMOD	O
O	O	O	958	962	mRNA	mRNA	I-NP	NN	B-RNA	11	NMOD	B-RNA
O	O	O	963	968	level	level	I-NP	NN	O	14	NMOD	O
O	O	O	969	972	and	and	I-NP	CC	O	14	NMOD	O
O	O	O	973	975	NO	NO	I-NP	NN	O	14	NMOD	O
O	O	O	976	986	generation	generation	I-NP	NN	O	19	SUB	O
O	O	O	987	989	in	in	B-PP	IN	O	14	NMOD	O
O	O	O	990	995	mouse	mouse	B-NP	NN	B-cell_type	18	NMOD	B-cell_type
O	O	O	996	1006	peritoneal	peritoneal	B-NP	JJ	I-cell_type	18	NMOD	I-cell_type
O	O	O	1007	1018	macrophages	macrophage	I-NP	NNS	I-cell_type	15	PMOD	I-cell_type
O	O	O	1019	1023	were	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1024	1034	suppressed	suppress	I-VP	VBN	O	19	VC	O
O	O	O	1035	1037	by	by	B-PP	IN	O	20	VMOD	O
O	O	O	1038	1040	10	10	B-NP	CD	O	27	AMOD	O
O	O	O	1040	1041	(	(	O	(	O	26	DEP	O
O	O	O	1041	1042	-	-	O	SYM	O	26	DEP	O
O	O	O	1042	1043	5	5	O	CD	O	24	PRD	O
O	O	O	1043	1044	)	)	O	)	O	22	NMOD	O
O	O	O	1045	1046	M	M	B-NP	NN	O	28	NMOD	O
O	O	O	1047	1054	Azeptin	Azeptin	I-NP	NN	O	21	PMOD	O
O	O	O	1054	1055	.	.	O	.	O	19	P	O

O	O	O	1056	1061	Being	Be	B-VP	VBG	O	16	SUB	O
O	O	O	1062	1072	compatible	compatible	B-ADJP	JJ	O	1	PRD	O
O	O	O	1073	1077	with	with	B-PP	IN	O	2	AMOD	O
O	O	O	1078	1083	those	those	B-NP	DT	O	5	NMOD	O
O	O	O	1084	1091	results	result	I-NP	NNS	O	3	PMOD	O
O	O	O	1091	1092	,	,	O	,	O	14	P	O
O	O	O	1093	1100	Azeptin	Azeptin	B-NP	NN	O	14	NMOD	O
O	O	O	1101	1102	(	(	O	(	O	13	DEP	O
O	O	O	1102	1104	10	10	B-NP	CD	O	13	DEP	O
O	O	O	1104	1105	(	(	O	(	O	13	DEP	O
O	O	O	1105	1106	-	-	O	SYM	O	13	DEP	O
O	O	O	1106	1107	5	5	O	CD	O	11	PRD	O
O	O	O	1107	1108	)	)	O	)	O	7	NMOD	O
O	O	O	1109	1110	M	M	B-NP	NN	O	1	OBJ	O
O	O	O	1110	1111	)	)	O	)	O	1	VMOD	O
O	O	O	1112	1122	suppressed	suppress	B-VP	VBD	O	0	ROOT	O
O	O	O	1123	1133	activation	activation	B-NP	NN	O	16	OBJ	O
O	O	O	1134	1136	of	of	B-PP	IN	O	17	NMOD	O
T9	B-Entity	B-Entity	1137	1139	NF	NF	B-NP	NN	B-protein	22	NMOD	B-protein
T9	I-Entity	I-Entity	1139	1140	-	-	B-NP	HYPH	I-protein	22	NMOD	I-protein
T9	I-Entity	I-Entity	1140	1145	kappa	kappa	I-NP	NN	I-protein	22	NMOD	I-protein
T9	I-Entity	I-Entity	1146	1147	B	B	I-NP	NN	I-protein	18	PMOD	I-protein
O	O	O	1148	1150	in	in	B-PP	IN	O	17	NMOD	O
O	O	O	1151	1154	PBL	PBL	B-NP	NN	B-cell_type	28	NMOD	B-cell_type
O	O	O	1154	1155	,	,	I-NP	,	O	28	P	O
O	O	O	1156	1158	HM	HM	I-NP	NN	B-protein	28	NMOD	B-protein
O	O	O	1159	1162	and	and	I-NP	CC	O	28	NMOD	O
O	O	O	1163	1165	HF	HF	I-NP	NN	B-protein	23	PMOD	B-protein
O	O	O	1165	1166	.	.	O	.	O	16	P	O

O	O	O	1167	1172	These	These	B-NP	DT	O	2	NMOD	O
O	O	O	1173	1180	results	result	I-NP	NNS	O	3	SUB	O
O	O	O	1181	1187	appear	appear	B-VP	VBP	O	0	ROOT	O
O	O	O	1188	1190	to	to	I-VP	TO	O	5	VMOD	O
O	O	O	1191	1199	indicate	indicate	I-VP	VB	O	3	VMOD	O
O	O	O	1200	1204	that	that	B-SBAR	IN	O	5	VMOD	O
O	O	O	1205	1216	suppression	suppression	B-NP	NN	O	15	SUB	O
O	O	O	1217	1219	of	of	B-PP	IN	O	7	NMOD	O
O	O	O	1220	1228	cytokine	cytokine	B-NP	NN	B-protein	12	NMOD	B-protein
O	O	O	1229	1232	and	and	I-NP	CC	O	12	NMOD	O
O	O	O	1233	1235	NO	NO	I-NP	NN	O	12	NMOD	O
O	O	O	1236	1246	generation	generation	I-NP	NN	O	8	PMOD	O
O	O	O	1247	1249	by	by	B-PP	IN	O	7	NMOD	O
O	O	O	1250	1257	Azeptin	Azeptin	B-NP	NN	O	13	PMOD	O
O	O	O	1258	1265	results	result	I-NP	NNS	O	6	SBAR	O
O	O	O	1266	1268	at	at	B-ADVP	IN	O	15	VMOD	O
O	O	O	1269	1274	least	least	I-ADVP	JJS	O	16	AMOD	O
O	O	O	1275	1284	partially	partially	B-ADVP	RB	O	15	VMOD	O
O	O	O	1285	1289	from	from	B-PP	IN	O	18	AMOD	O
O	O	O	1290	1293	the	the	B-NP	DT	O	21	NMOD	O
O	O	O	1294	1304	inhibition	inhibition	I-NP	NN	O	19	PMOD	O
O	O	O	1305	1307	of	of	B-PP	IN	O	21	NMOD	O
T10	B-Entity	B-Entity	1308	1310	NF	NF	B-NP	NN	B-protein	27	NMOD	B-protein
T10	I-Entity	I-Entity	1310	1311	-	-	B-NP	HYPH	I-protein	27	NMOD	I-protein
T10	I-Entity	I-Entity	1311	1316	kappa	kappa	I-NP	NN	I-protein	27	NMOD	I-protein
T10	I-Entity	I-Entity	1317	1318	B	B	I-NP	NN	I-protein	27	NMOD	I-protein
O	O	O	1319	1329	activation	activation	I-NP	NN	O	22	PMOD	O
O	O	O	1329	1330	.	.	O	.	O	3	P	O
